| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0335 | 7-hcaa | Fluorescent amino acid for protein labeling |
|
| DCC0336 | 7-hydroxyneolamellarin A | Natural hypoxia-inducible factor-1α (HIF-1α) inhibitor, targeting the protein activity which could stabilize HIF-1α |
|
| DCC0337 | 7-meota | Potent inhibitor of AChE in treatment of cognitive manifestation of AD |
|
| DCC0338 | 7-nina | Non-selective NOS inhibitor |
|
| DCC0339 | 7-nitrocalindol Hydrochloride | Potent and selective calcium sensing receptor agonist |
|
| DCC0340 | 7-oxo-staurosporine (chair Isomer) | Potent dual PKCθ/δ inhibitor, efficiently inhibiting tumor growth in pancreatic cancer (PC) by inducing cellular apoptosis and suppressing the NF-κB/p-P65 pathway |
|
| DCC0341 | 7-troc-paclitaxel | Precursor of paclitaxel, a anti-tumor agent |
|
| DCC0342 | 808-nm2 | Novel tumor-targeting NIR fluorophore-conjugated hypoxic tumor inhibitor, preferentially accumulating in hypoxic tumor cells, sensitively outlining the tumor contour, and effectively inhibiting tumor growth synergistically by chemotherapy and radiotherapy |
|
| DCC0343 | 8-aaf-dg | Carcinogenic adduct, covalently binding DNA bases and promoting mutagenesis near the adduct site |
|
| DCC0344 | 8-aha-2-cl-camp | Novel activator of cAMP-dependent protein kinase (PKA) with high selectivity for site B-I of PKA |
|
| DCC0345 | 8-bus-adenosine | Building block for syntheses of 8-BuS-AMP, ADP, ATP, and c-AMP |
|
| DCC0346 | 8-bus-adp Trisodium | Potent and selective inhibitor of NTPDase1 |
|
| DCC0347 | 8-bus-amp Disodium | Potent and selective inhibitor of NTPDase1 |
|
| DCC0348 | 8-bus-atp Tetrasodium | Potent and selective inhibitor of NTPDase1 |
|
| DCC0349 | 8-chloro-5-nitro-acridin-2,9-diol | Building Block |
|
| DCC0350 | 8-chloroadenosine | Inhibitor of RNA synthesis |
|
| DCC0351 | 8-cl-tibo | Specific non-nucleoside RT inhibitor (NNRTI) of HIV-1 RT |
|
| DCC0352 | 8-gly-carb | Novel inhibitor of nitric oxide formation in macrophages independent of effects on TNF |
|
| DCC0353 | 8-hydroxy-2-quinolinecarbaldehyde | Antitumor agent, displaying cytotoxicity against the human cancer cell lines, including MDA231, T-47D, Hs578t, SaoS2, K562, SKHep1,and Hep3B |
|
| DCC0354 | 8-nitro-cgmp | Unique cytoprotective mediator, inhibiting oxidative stress; Novel probe of the protein S-guanylation |
|
| DCC0355 | 8-pcpt-cgmp | Potent activator of cGMP-dependent protein kinase Ia, Ib and type II as well as of cGMP- gated ion channels |
|
| DCC0356 | 8-pip-camp | Potent and selective activator of protein kinase A (PKA) type I and II |
|
| DCC0357 | 9-deaza-csc | Dual human A2a antagonist/MAO-B inhibitor |
|
| DCC0358 | 9-hode | Endogenous peripheral TRPV1 ligand |
|
| DCC0359 | 9-ing-87 | Novel ATP-competitive GSK-3ß inhibitor, exhibiting potent antiproliferative activity |
|
| DCC0360 | 9-isopropylolomoucine | Inhibitor of cyclin-dependent kinases |
|
| DCC0361 | 9-me-1 | Novel, potent, mutant-selective BET bromodomain inhibitor, showing >100-fold selectivity for the L/V mutant over wild-type and excellent DMPK properties |
|
| DCC0362 | 9'-methoxypinoresinol | Novel natural anticancer agent, exhibiting potent cytotoxicity against PANC-1 human pancreatic cancer cell line under the normoglycemic condition |
|
| DCC0363 | 9-o-demethyltrigonostemone | Natural IDO1 inhibitor, cytotoxic and antiplasmodial agent |
|
| DCC0364 | A-1098807 | Selective TRPV1 antagonist |
|
